Trust Point Inc. trimmed its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 42.7% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 6,382 shares of the business services provider's stock after selling 4,747 shares during the quarter. Trust Point Inc.'s holdings in Exponent were worth $517,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently modified their holdings of EXPO. Private Trust Co. NA boosted its holdings in shares of Exponent by 129.8% in the 4th quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after buying an additional 157 shares during the last quarter. Atala Financial Inc acquired a new position in Exponent in the 4th quarter valued at about $25,000. Whipplewood Advisors LLC increased its stake in shares of Exponent by 5,333.3% during the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock worth $26,000 after purchasing an additional 320 shares during the period. Tortoise Investment Management LLC lifted its holdings in shares of Exponent by 76.7% during the fourth quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider's stock worth $39,000 after buying an additional 191 shares in the last quarter. Finally, Brown Brothers Harriman & Co. acquired a new stake in Exponent in the 4th quarter worth about $50,000. 92.37% of the stock is currently owned by institutional investors.
Exponent Stock Performance
Shares of NASDAQ EXPO traded down $2.19 during mid-day trading on Friday, reaching $72.86. The company had a trading volume of 304,085 shares, compared to its average volume of 256,439. The business's 50-day simple moving average is $77.65 and its 200 day simple moving average is $84.17. Exponent, Inc. has a one year low of $72.85 and a one year high of $115.75. The firm has a market cap of $3.70 billion, a price-to-earnings ratio of 35.54 and a beta of 0.92.
Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 18.87% and a return on equity of 25.33%. The firm had revenue of $137.44 million during the quarter, compared to analyst estimates of $134.63 million. During the same quarter last year, the business earned $0.59 EPS. The company's revenue was up .2% compared to the same quarter last year. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, June 6th. This represents a $1.20 annualized dividend and a dividend yield of 1.65%. Exponent's dividend payout ratio is presently 58.54%.
Insider Transactions at Exponent
In related news, VP John Pye sold 2,000 shares of Exponent stock in a transaction dated Friday, May 23rd. The stock was sold at an average price of $76.32, for a total value of $152,640.00. Following the completion of the sale, the vice president now owns 29,204 shares of the company's stock, valued at approximately $2,228,849.28. This trade represents a 6.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, VP Bradley A. James sold 2,694 shares of the company's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. Insiders have sold 6,267 shares of company stock valued at $489,120 over the last ninety days. 1.60% of the stock is owned by company insiders.
About Exponent
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.